235 related articles for article (PubMed ID: 29634665)
1. Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.
Oki Y; Ono M; Hyogo H; Ochi T; Munekage K; Nozaki Y; Hirose A; Masuda K; Mizuta H; Okamoto N; Saibara T
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):797-805. PubMed ID: 29634665
[TBL] [Abstract][Full Text] [Related]
2. The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.
Morio R; Hyogo H; Hatooka M; Morio K; Kan H; Kobayashi T; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Aikata H; Ochi H; Masayasu Y; Chayama K
J Gastroenterol; 2017 Feb; 52(2):253-262. PubMed ID: 27351871
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD.
Coccia F; Testa M; Guarisco G; Di Cristofano C; Silecchia G; Leonetti F; Gastaldelli A; Capoccia D
Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):106-113. PubMed ID: 31677889
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
Haliloglu B; Gokdemir Y; Atay Z; Abali S; Guran T; Karakoc F; Ersu R; Karadag B; Turan S; Bereket A
Pediatr Diabetes; 2017 Nov; 18(7):607-613. PubMed ID: 27873431
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
[TBL] [Abstract][Full Text] [Related]
6. Significance of oral glucose tolerance tests in non-alcoholic fatty liver disease patients with a fasting plasma glucose level of <126 mg/dL and HbA1c level of ≤ 6.4% in Japan.
Matsumoto N; Arase Y; Kawamura Y; Ohmoto-Sekine M; Amakawa K; Ogawa K; Tsuji H; Dong HS; Hara S; Akuta N; Suzuki F; Suzuki Y; Ikeda K; Kumada H; Kobayashi T
Intern Med; 2015; 54(8):875-80. PubMed ID: 25876566
[TBL] [Abstract][Full Text] [Related]
7. Prediction of nocturnal hypoglycemia unawareness by fasting glucose levels or post-breakfast glucose fluctuations in patients with type 1 diabetes receiving insulin degludec: A pilot study.
Takahashi H; Nishimura R; Onda Y; Ando K; Tsujino D; Utsunomiya K
PLoS One; 2017; 12(7):e0177283. PubMed ID: 28683068
[TBL] [Abstract][Full Text] [Related]
8. Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.
Hashiba M; Ono M; Hyogo H; Ikeda Y; Masuda K; Yoshioka R; Ishikawa Y; Nagata Y; Munekage K; Ochi T; Hirose A; Nozaki-Fujimura Y; Noguchi S; Okamoto N; Chayama K; Suganuma N; Saibara T
PLoS One; 2013; 8(11):e76161. PubMed ID: 24223115
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
Guo M; Xi G; Yang N; Yao H
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
[TBL] [Abstract][Full Text] [Related]
10. Continuous glucose monitoring and HbA1c in the evaluation of glucose metabolism in children at high risk for type 1 diabetes mellitus.
Helminen O; Pokka T; Tossavainen P; Ilonen J; Knip M; Veijola R
Diabetes Res Clin Pract; 2016 Oct; 120():89-96. PubMed ID: 27525364
[TBL] [Abstract][Full Text] [Related]
11. Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia.
Suzuki H; Fukushima M; Usami M; Ikeda M; Taniguchi A; Nakai Y; Matsuura T; Kuroe A; Yasuda K; Kurose T; Seino Y; Yamada Y
Diabetes Care; 2003 Apr; 26(4):1211-5. PubMed ID: 12663599
[TBL] [Abstract][Full Text] [Related]
12. Post-prandial hypoglycemia results from a non-glucose-dependent inappropriate insulin secretion in Roux-en-Y gastric bypassed patients.
Vaurs C; Brun JF; Bertrand M; Burcelin R; du Rieu MC; Anduze Y; Hanaire H; Ritz P
Metabolism; 2016 Mar; 65(3):18-26. PubMed ID: 26892512
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing--the iBolus--in subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: a randomized controlled trial.
Rossetti P; Ampudia-Blasco FJ; Laguna A; Revert A; Vehì J; Ascaso JF; Bondia J
Diabetes Technol Ther; 2012 Nov; 14(11):1043-52. PubMed ID: 23003329
[TBL] [Abstract][Full Text] [Related]
14. Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.
Bonora E
Int J Clin Pract Suppl; 2002 Jul; (129):5-11. PubMed ID: 12166607
[TBL] [Abstract][Full Text] [Related]
15. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.
Kuzuya T; Nakagawa S; Satoh J; Kanazawa Y; Iwamoto Y; Kobayashi M; Nanjo K; Sasaki A; Seino Y; Ito C; Shima K; Nonaka K; Kadowaki T;
Diabetes Res Clin Pract; 2002 Jan; 55(1):65-85. PubMed ID: 11755481
[TBL] [Abstract][Full Text] [Related]
16. Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes.
Hanefeld M; Koehler C; Hoffmann C; Wilhelm K; Kamke W; Gerstein H
Diabet Med; 2010 Feb; 27(2):175-80. PubMed ID: 20546261
[TBL] [Abstract][Full Text] [Related]
17. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
18. Reduced postprandial GLP-1 responses in women with gestational diabetes mellitus.
Bonde L; Vilsbøll T; Nielsen T; Bagger JI; Svare JA; Holst JJ; Larsen S; Knop FK
Diabetes Obes Metab; 2013 Aug; 15(8):713-20. PubMed ID: 23406269
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of carotid intima media thickness in impaired fasting glucose and impaired glucose tolerance.
Aydin Y; Berker D; Ustün I; Gül K; Erden G; Kutlucan A; Yilmaz Aydin L; Güler S
Minerva Endocrinol; 2011 Sep; 36(3):171-9. PubMed ID: 22019748
[TBL] [Abstract][Full Text] [Related]
20. Glycated Hemoglobin Is Suboptimal for the Screening of Prediabetes and Type 2 Diabetes in Adults With Nonalcoholic Fatty Liver Disease.
Gignac T; Trépanier G; Paquet V; Ferland S; Carreau AM
Can J Diabetes; 2023 Oct; 47(7):603-610. PubMed ID: 37352972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
